Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition
Precigen, Inc.
A biopharmaceutical company in Germantown, Maryland, that develops precision medicines for cancer, autoimmune disorders, and infectious diseases. It grew out of Intrexon, a synthetic biology firm founded in 1998, and in 2020 the whole company rebranded as Precigen to focus entirely on human health. Its name blends "precision" and "genetics," and its UltraCAR-T platform can engineer a patient's own immune cells overnight at the hospital using a non-viral "Sleeping Beauty" gene-delivery system.
2.02 Results of Operations and Financial Condition
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
3.02 Unregistered Sales of Equity Securities
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits